头孢泊肟

头孢泊肟性质、用途与生产工艺

用途

虽然头孢泊肟酸不适于口服给药，但是，其酯衍生物1-(异丙氧羰基氧基)乙酯，即头孢泊肟酯(cefpodoximeproxetil)，是宝贵的口服抗生素，其特点是对革兰氏阳性的和革兰氏阴性的微生物有非常高的广谱活性。

头孢泊肟 上下游产品信息

上游原料

下游产品

头孢泊肟 生产厂家

80210-62-4, 头孢泊肟 相关搜索:

• Pharmaceuticals
• Metabolites & Impurities
• Intermediates & Fine Chemicals
• Sulfur & Selenium Compounds
• Heterocycles
• Various Metabolites and Impurities
• 头孢泊肟酯杂质
• 化学试剂
• 杂质对照品
• 医药原料药
• 化药杂质-头孢泊肟酯
• 生化试剂
• 原料
• 对照品-杂质对照品
• 中间体
• 头孢泊肟 PROXETIL EP 杂质 A(头孢泊肟酸)
• 头孢泊肟酯杂质1(头孢泊肟酯EP杂质A)
• 头孢泊肟酯酸
• 头孢泊肟酯杂质A(EP)
• 头孢泊肟酯EP杂质A(头孢泊肟酸)
• 头孢泊肟酯杂质A (6R,7R)-7-[(Z)-2-(2-氨基噻唑-4-基-2-(甲氧基亚氨基)乙酰氨基]-3-(甲氧基甲基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸
• 头孢泊肟酯杂质A （6R，7R）-7-[（Z）-2-（2-氨基噻唑-4-基-2-（甲氧基亚氨基）乙酰氨基]-3-（甲氧基甲基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-羧酸
• 头孢泊肟杂质
• 原料药头孢泊肟酯 杂质A
• 头孢泊肟酯EP杂质A
• 头孢泊肟酸
• (6R,7R)-7-[2-(2-氨基-4-噻唑基)-(Z)-2-(甲氧亚氨基)乙酰氨基]-3-甲氧甲基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-2-甲酸
• 头孢泊肟
• 80210-62-4
• Cefpodoxime,Bacterial,gram-negative bacteria,R-3763,Cefpodoxime (free acid),Cefpodoxime acid,Antibiotic,R 3763,Inhibitor,R3763,gram-positive bacteria,inhibit
• Cefpodoxime tablet 200mg
• CefpodoximeAcidQ: What is CefpodoximeAcid Q: What is the CAS Number of CefpodoximeAcid Q: What is the storage condition of CefpodoximeAcid Q: What are the applications of CefpodoximeAcid
• Cefpodoxime D3 AcidQ: What is Cefpodoxime D3 Acid Q: What is the CAS Number of Cefpodoxime D3 Acid Q: What is the storage condition of Cefpodoxime D3 Acid Q: What are the applications of Cefpodoxime D3 Acid
• Cefpodoxime USP/EP/BP
• Cefpodoxime Proxetil Impurity 1（EP Impurity A）
• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, (6R,7R)-
• Cefpodoxime Proxetil EP Impurity A
• Cefpodoxime Proxetil Impurity 1(Cefpodoxime Proxetil EP Impurity A)
• (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• Cefpodoxime proxetil Impurity A:( (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid(Cefpodoxime Acid)
• Cefpodoxime Proxetil EP Impurity A (Cefpodoxime Acid)
• Cefpodoxime Proxetil impurity 1/Cefpodoxime Proxetil EP Impurity A/ Cefpodoxime Acid/(6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• Cefpodoxime-D3Acid(98%,99Atom%D)
• (6R,7R)-7α-[[(2-Amino-4-thiazolyl)[(Z)-methoxyimino]acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid
• Cefpodoxime
• (6R-(6alpha,7beta(Z)))-7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• Cefpodoxime sulfate
• (6R,7R)-7-{2-(2-Amino-4-thiazolyl)-2-[(Z)-methoxyimino]acetamido}-3-(methoxymethyl)-3-cephem-4-carboxylate
• Unii-7R4F94tvgy
• Cefpodoximum [latin]
• Cefpodoximum
• Cefpodoxima [spanish]
• Cefpodoxima
• 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, (6R-(6alpha,7beta(Z)))-
• CPDX
• (7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetyl]amino]-3-methoxymethylcepham-3-ene-4-carboxylic acid
• (6R,7R)-7α-[[(2-Aminothiazol-4-yl)[(Z)-methoxyimino]acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid